Cue Biopharma (CUE)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.14B
EV to revenue ratio (TTM)
3.52
EV to ebitda
-1.76
Financial Performance
Revenue (TTM)
$0.04B
Gross profit (TTM)
-$0.04B
EBITDA
-$0.10B
Profitability
Operating margin (TTM)
-1,113.00%
Profit margin
<0.01%
Return on assets (TTM)
-172.70%
Return on equity (TTM)
-1,603.00%
Per Share Metrics
Revenue per share (TTM)
$8.31
EPS
-$29.59
Diluted EPS (TTM)
-$29.59
Book value
$0.44
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
n/a
Price to sales ratio (TTM)
3.62
Price to book ratio (TTM)
63.56
Growth
Quarterly earnings growth (YoY)
166.70%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
0
Buy
3
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
2.81